Skip to main content
Premium Trial:

Request an Annual Quote

TGen Spurs Software Firm to Open in Phoenix

NEW YORK, June 26 - Life sciences software firm 5AM Solutions has opened its doors in Phoenix to be near the Translational Genomics Research Institute, the firm and TGen said today.

 

5AM is headed up by Brent Gendleman (CEO) and Rob Daly (COO), who recently relocated to Phoenix from the Washington, DC area.

 

The firm is currently working on TGen's bioinformatics facility, as well as a data collection system for a national microarray consortium. Dietrick Stephan, director of the TGen Neurogenomics Division, is overseeing this national microarray consortium project, which is funded by NIMH and NINDS.

 

"Everyone who helped establish TGen hoped the institute would bring new businesses to Arizona.  Now we see that expectation was accurate," said Richard Love, TGen's COO, in a statement.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.